Our results show that simultaneously blocking EGFR with gefitinib and COX-2 with NS-398 in PCa cells subjected to low-dose docetaxel resulted in a beneficial effect on cell growth inhibition (Figure 3). The gene discussed is PTGS2; the disease is posterior cortical atrophy.